The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

901 NEW YORK AVENUE, NW, WASHINGTON, DC 20001-4413, USA
Tel:
Work +1 202 408 4000
Web:
www.finnegan.com

Michele C. Bosch

Tel:
Work +1 202 408 4193
Email:
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Work Department

Intellectual Property

Career

Michele Bosch’s practice includes many areas of intellectual property law with an emphasis on post-grant proceedings, including inter partes review (IPR) and post-grant review (PGR) matters before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), patent interference proceedings, portfolio management and analysis, due diligence investigations, pre-litigation analysis, and comprehensive strategic client counseling.

Member

  • American Intellectual Property Association
  • Intellectual Property Owners Association
  • American Bar Association
  • Virginia Bar Association
  • District of Columbia Bar Association
  • Federal Circuit Bar Association
  • American Chemical Society

Education

College of William and Mary
J.D., 1993
University of Virginia
B.A., Chemistry, 1990


United States: Intellectual property

Patents: licensing

Within: Patents: licensing

IP giant Finnegan, Henderson, Farabow, Garrett & Dunner LLP excels in patent portfolio analysis and monetization and acts for a diverse client base that includes major multinationals such as Abbott Vascular, Otsuka Pharmaceuticals and LG Electronics alongside start-ups. The group is adept at negotiating and drafting agreements for business and technical collaborations, and has strong experience in handling corporate transactional work, including due diligence. Litigation settlement agreements are another key strength. Reston’s Anthony Gutowski and Washington DC’s William Pratt advised Toyota on multiple patent and technology licence agreements, including contracts with universities, research agreements with government laboratories, and commercial transactions, and non-profit institute Cognitive Research Enterprises engaged the team to assist with the licensing aspects of the acquisition of most of its IP assets. In a recent example of pharmaceutical work, the group negotiated an exclusive licence agreement for Dermavant Sciences with Portola Pharmaceuticals for the development and commercialisation of a hematologic cancer treatment. Other mandates stemmed from the chemical, robotics and electronics sectors. The firm’s deep bench also includes practice head John Paul, managing partner Mark Sweet, Doris Johnson Hines, Michele Bosch, Adriana Burgy, and Brian Kacedon, all from the Washington DC office.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to